Search Results

Testing the unintended cost effects of health policies for generic substitutions: the case of China's National Volume-Based Procurement (NVBP) policy.

• Authors : Zhao, Boya^1,2 (AUTHOR); Wu, Jing^2,3 (AUTHOR); Feng, Xing Lin¹ (AUTHOR)

Subjects: *DRUG prices; *CALCIUM antagonists; *COST control

• Source: Health Policy & Planning. Mar2025, Vol. 40 Issue 2, p194-205. 12p.

Record details

Can the FDA Help Reduce Drug Prices or the Cost of Medical Care?

• Authors : Zuckerman DM; Diana M. Zuckerman is the president of the National Center for Health Research, Washington, DC.

Subjects: Guidelines as Topic*; Cost Control/Cost Control/Cost Control/*standards ; Delivery of Health Care/Delivery of Health Care/Delivery of Health Care/*economics

• Source: American journal of public health [Am J Public Health] 2017 Nov; Vol. 107 (11), pp. 1752-1754.Publisher: American Public Health Association Country of Publication: United States NLM ID: 1254074 Publication Model: Print Cited Medium: Internet

Record details

临床药师干预对脑卒中患者合理使用依达拉奉 右莰醇注射用浓溶液的效果分析.

• Authors : 赵 洋¹ ; 马泉吉¹; 吴建章^2,3

• Source: Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi. 2024, Vol. 24 Issue 8, p1007-1015. 4p.

Record details

Trastuzumab plus chemotherapy versus chemotherapy alone in HER2-positive gastric cancer treatment in Iran: a cost-effectiveness analysis.

• Authors : Kaveh, Sara (AUTHOR); Ghadimi, Nashmil (AUTHOR); Zarei Alvar, Amirhossein (AUTHOR)

Subjects: ADVERSE health care events; ECONOMIC aspects of diseases; PROGRESSION-free survivalIRAN

• Source: Health Economics Review. 11/9/2024, Vol. 14 Issue 1, p1-14. 14p.

Record details

Reducing drug prices.

• Authors : Epstein RA

Subjects: Cost Control* ; Drug Costs*; Drug Industry/Drug Industry/Drug Industry/*economics

• Source: Health affairs (Project Hope) [Health Aff (Millwood)] 2004 Nov-Dec; Vol. 23 (6), pp. 276; author reply 277.Publisher: Project Hope Country of Publication: United States NLM ID: 8303128 Publication Model: Print Cited Medium: Print ISSN: 0278-2715

Record details

Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs.

• Authors : Wong, William Bruce¹ (AUTHOR); Seetasith, Arpamas¹ (AUTHOR); Hung, Anna^2,3,4 (AUTHOR)

Subjects: *PRICES; *PATIENT compliance; *HEPATITIS C virus

• Source: PLoS ONE. 1/19/2023, Vol. 18 Issue 1, p1-16. 16p.

Record details

Older Americans' Preferences Between Lower Drug Prices and Prescription Drug Plan Choice, 2019.

• Authors : Socal, Mariana P. (AUTHOR); Anderson, Gerard F. (AUTHOR)

Subjects: DRUGS & economics; COST control; HEALTH status indicatorsUNITED States

• Source: American Journal of Public Health. Mar2020, Vol. 110 Issue 3, p354-356. 3p.

Record details

Clinical cost evaluation and health benefits of post‐bariatric intervention for patients with type 2 diabetes living in the UK.

• Authors : Alkharaiji, Mohammed^1,2 (AUTHOR); Anyanwagu, Uchenna¹ (AUTHOR); Crabtree, Thomas¹ (AUTHOR)

• Source: Clinical Obesity. Dec2021, Vol. 11 Issue 6, p1-10. 10p.

Record details

Controlling Costs and Enhancing the Patient Journey in a Changing Pharmaceutical Landscape.

• Authors : MCNULTY, ROSE

Subjects: COST control; MEDICAL personnel; LANDSCAPE changes

• Source: American Journal of Accountable Care. Dec2023, Vol. 11 Issue 4, p72-77. 4p.

Record details

The Effects of Cost Containment and Price Policies on Pharmaceutical Expenditure in South Korea.

• Authors : Woohyeon Kim; Heejo Koo; Hye-Jae Lee

Subjects: COST control; PHARMACEUTICAL policy; DRUG pricesSOUTH Korea

• Source: International Journal of Health Policy & Management. Oct2022, Vol. 11 Issue 10, p2198-2207. 10p.

Record details